跳至主要内容
临床试验/CTRI/2023/09/058110
CTRI/2023/09/058110招募中2 期

se of intracavernosal injection of autologous platelet rich plasma for the treatment of mild to moderate erectile dysfunction: A placebo controlled, parallel group, double blind randomized clinical trail - nil

All India Institute of Medical Sciences Raipur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Male patients aged 21-75 years
  • 2. Patients with well-established chronic ED for at least 3 months
  • 3. IIEF-EF score 11-25 at screening (even if taking a single PDE5I)
  • 4. sexually active in a heterosexual stable partnership for at least 3 months will be considered for study
  • 5. Patients must be willing to comply with the key requests of the trial, namely to maintain regular sexual activities during the entire course of the trial with a mean frequency of sexual activities of at least once per week and comply with study related tests and procedures
  • 6. must give up any other EF enhancing treatment, including hormonal (T) replacement therapy with study entrance.

排除标准

  • 1. Previous surgery of penile fracture/ hypospadias/penile reconstructive surgery. 2. history of significant psychiatric disease/BPD
  • 3. untreated hypogonadism
  • 4. uncontrolled DM (HBA1c > 9%)
  • 5. patients using intra-cavernosal injection of vasoactive substances for ED
  • 6. developing priapism during before or during study period

研究者

相似试验